(Q43891588)

27 November 2017

The Children Leukemia Group: 30 years of research and achievements (English)

1 reference

27 November 2017

J Otten

1

1 reference

27 November 2017

N Philippe

2

1 reference

27 November 2017

S Suciu

3

1 reference

27 November 2017

C Béhar

4

1 reference

27 November 2017

A Babin-Boilletot

5

1 reference

27 November 2017

A Thyss

6

1 reference

27 November 2017

A Ferster

7

1 reference

27 November 2017

E Vilmer

8

1 reference

27 November 2017

EORTC Children Leukemia Group

9

1 reference

27 November 2017

1 March 2002

1 reference

European Journal of Cancer

27 November 2017

1 reference

27 November 2017

38 Suppl 4

1 reference

27 November 2017

S44-9

1 reference

Treatment strategy for different risk groups in childhood acute lymphoblastic leukemia: A Report From the BFM Study Group

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900449-X

7 January 2021

Treatment of acute lymphoblastic leukemia in children with the BFM protocol. A cooperative pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900449-X

7 January 2021

Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900449-X

7 January 2021

Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatme

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900449-X

7 January 2021

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900449-X

7 January 2021

Systemic effect of intrathecal methotrexate during the initial phase of treatment of childhood acute lymphoblastic leukemia. The European Organization for Research and Treatment of Cancer Children's Leukemia Cooperative Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900449-X

7 January 2021

Improved survival for acute lymphoblastic leukaemia in infancy: the experience of EORTC-Childhood Leukaemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2801%2900449-X

7 January 2021

10.1016/S0959-8049(01)00449-X

Identifiers

DOI

1 reference

27 November 2017

1 reference